Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by Stifel Nicolaus

Stifel Nicolaus started coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a note issued to investors on Monday,Benzinga reports. The brokerage set a “buy” rating and a $28.00 price target on the stock. Stifel Nicolaus’ price target suggests a potential upside of 19.50% from the company’s previous close.

Kestra Medical Technologies Trading Down 2.5 %

Shares of NASDAQ:KMTS opened at $23.43 on Monday. Kestra Medical Technologies has a 12 month low of $20.00 and a 12 month high of $25.98.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.